Afif Ghannoum on Clubhouse

Updated: Feb 22, 2024
Afif Ghannoum Clubhouse
158 Followers
213 Following
Jan 5, 2021 Registered
@afif Username

Bio

CEO of BIOHM Health


I have spent my career taking scientific innovations and turning them into innovative companies, products and testing services.

I’ve done that through my own companies and brands, as well as licensing IP to companies around the world. My products and technologies have been sold in over 100,000 retail stores, online and by noted medical institutions, such as the Cleveland Clinic. Our data and testing companies have partnered with some of the biggest pharmaceutical companies in the world.

Innovation Awards:
ECRM’s Best New Cough Cold Product Award
Nutrition Business Journal’s Science & Innovation Award

Innovation Summit Corporate Presentations
- Herbalife
- Standard Process
- DSM (makers of Culturelle)

Forbes has featured my innovations extensively.

I also work with scientific experts, and turn their expertise into consumer platforms.
E.g., for Dr Mahmoud Ghannoum, the leading expert on medically important fungi:

- Turned expertise into consumer products sold in over 27,000 stores

- Secured a book deal for his book, Total Gut Balance, a diet book around optimizing gut fungi

- Secured press for Dr Ghannoum in hundreds of outlets from NPR, and the Wall Street Journal, to Women’s Health, Goop, MindBodyGreen and Goop.

- Launched DrMicrobiome.com, his personal platform reaching tens of thousands of consumers a month

Additional accomplishments:

Raised $17 million+ in venture capital

Launched the first at-home microbiome test that tracks bacteria AND fungi in the gut

Launched and sold consumer products in over 27,000 stores (including Walmart, Target, CVS, Walgreens, Rite Aid and Bed Bath & Beyond)

Licensed IP from a Top 25 Medical Institution, turning that IP into an award winning probiotic brand

Launched Next Trillion Sciences, one of the leading microbiome CRO's in the world

Secured a patent using the USPTO's rarely invoked, Commercial Success doctrine, which finds innovation and patentability based on commercial success

Licensed a technology to a global pharma company for an OTC product sold in over 100,000 stores

Invited by: Paul Frantellizzi

Last 10 Records

if the data has not been changed, no new rows will appear.

Day Followers Gain % Gain
February 22, 2024 158 -2 -1.3%
March 18, 2023 160 0 0.0%
January 21, 2023 160 +2 +1.3%
September 28, 2022 158 -1 -0.7%
May 25, 2022 159 +2 +1.3%
April 17, 2022 157 +1 +0.7%
January 11, 2022 156 +1 +0.7%
October 27, 2021 155 +1 +0.7%
September 20, 2021 154 +2 +1.4%

Charts

Member of

More Clubhouse users